fluconazole has been researched along with Chronic Kidney Failure in 37 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After administration of atorvastatin, amiodarone, and fluconazole, rhabdomyolysis developed with electrolyte disturbances (hyperphosphatemia, hyopcalcemia) and a massive increase in creatine kinase and myoglobin." | 7.77 | [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. ( Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE, 2011) |
| "Candida peritonitis was treated with fluconazole in ten continuous ambulatory peritoneal dialysis (CAPD) patients without immediate removal of the peritoneal catheter." | 7.69 | Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter. ( Aguirre, R; González, O; Martinez, I; Montenegro, J; Saracho, R, 1995) |
| "Fluconazole proved effective in treating fungal peritonitis caused by Trichosporon cutaneum." | 7.67 | Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report. ( Ahlmén, J; Carlsson, L; Edebo, L; Eriksson, C; Torgersen, AK, 1989) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 5.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| " After administration of atorvastatin, amiodarone, and fluconazole, rhabdomyolysis developed with electrolyte disturbances (hyperphosphatemia, hyopcalcemia) and a massive increase in creatine kinase and myoglobin." | 3.77 | [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. ( Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE, 2011) |
| "Candida peritonitis was treated with fluconazole in ten continuous ambulatory peritoneal dialysis (CAPD) patients without immediate removal of the peritoneal catheter." | 3.69 | Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter. ( Aguirre, R; González, O; Martinez, I; Montenegro, J; Saracho, R, 1995) |
| "Fluconazole proved effective in treating fungal peritonitis caused by Trichosporon cutaneum." | 3.67 | Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report. ( Ahlmén, J; Carlsson, L; Edebo, L; Eriksson, C; Torgersen, AK, 1989) |
| "Fluconazole (FLU) is a widely used antifungal agent." | 2.68 | Pharmacokinetics of fluconazole in renal failure. ( Baris, BA; Berl, T; Farmer, B; Gardner, M; Hansen, RA; Henrich, WL; Wilner, KD, 1995) |
| "Graft site candidiasis is a rare but life-threatening complication of renal transplant." | 1.39 | Candida arteritis in a pair of renal transplant recipients. ( Ashley, S; Barwell, J; Chinai, N; Cunningham, R; Guy, A; Rowe, P, 2013) |
| "Peritonitis is a common problem in patients undergoing peritoneal dialysis." | 1.38 | Successful treatment of peritonitis by C. bertholletiae in a chronic kidney failure patient on continuous ambulatory peritoneal dialysis after kidney rejection. ( Bhutada, K; Borkar, SS; Mendiratta, DK; Shende, VR, 2012) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 1.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Fungal spondylodiscitis is often because of Candida albicans or other common Candida species, whereas unusual strains such as Candida sake are often thought to be nonpathogenic." | 1.37 | Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient. ( Benecchi, M; Buzio, C; De Filippo, M; Maggiore, U; Palmisano, A; Vaglio, A, 2011) |
| "Fluconazole resistance was observed among 26% of all Candida isolates and 17." | 1.37 | An observational study on the epidemiological and mycological profile of Candidemia in ICU patients. ( Biswas, D; Gupta, A; Jindal, P; Kotwal, A; Sharma, JP, 2011) |
| "Peritonitis is a frequent complication in patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) treatment." | 1.32 | Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD). ( González-Monroy, J; Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ, 2003) |
| "Fungal peritonitis is rarely encountered." | 1.31 | Trichosporon beigelii peritonitis in a HIV-positive patient on continuous ambulatory peritoneal dialysis. ( Agarwal, SK; Anuradha, S; Bajaj, J; Chatterjee, A; Kaur, R; Singh, NP, 2000) |
| "To investigate the pharmacokinetic characteristics of intraperitoneal fluconazole in patients undergoing continuous cycling peritoneal dialysis (CCPD)." | 1.30 | Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. ( Dahl, NV; Fein, JL; Foote, EF; Kapoian, T; Searson, KM; Sherman, RA; Steward, CA, 1998) |
| "Fungal peritonitis is rare in our CPD population, and although it leads to significant CPD drop-out, it can be managed in many patients with antifungal therapy, early catheter removal, and temporary hemodialysis." | 1.29 | Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. ( Dunne, D; Finkelstein, FO; Goldie, SJ; Gorban-Brennan, N; Kiernan-Tridle, L; Kliger, AS; Torres, C, 1996) |
| "Fluconazole 200 mg was given orally (po) as first dose at the onset of antibiotic therapy, then 100 mg po every other day, and was continued for one week after the antibiotic therapy." | 1.29 | Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. ( Cabralda, T; Suh, H; Wadhwa, NK, 1996) |
| "We report here a case of Histoplasma capsulatum infection in such a Hong Kong Chinese patient who presented with fever and peritonitis." | 1.28 | Histoplasma capsulatum infection associated with continuous ambulatory peritoneal dialysis. ( Chan, PC; Chau, SP; Cheng, IK; Lim, W, 1991) |
| " The pharmacokinetics of fluconazole were markedly affected by impaired renal function with the elimination of half-life in Group III (GFR less than 20 ml min-1) being approximately three times that observed in normal volunteers (Group I)." | 1.28 | An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole. ( Gokal, R; Ross, CE; Rowland, M; Toon, S, 1990) |
| " The half-life (72 to 85 hours) was intermediate between values obtained in healthy volunteers and in patients with renal insufficiency studied during an interhaemodialysis period." | 1.28 | Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis. ( Bigot, MC; Debruyne, D; Hurault de Ligny, B; Levaltier, B; Moulin, M; Ryckelynck, JP, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 17 (45.95) | 18.2507 |
| 2000's | 6 (16.22) | 29.6817 |
| 2010's | 13 (35.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamil, B | 1 |
| Mukhtar Bokhari, MT | 1 |
| Saeed, A | 1 |
| Mukhtar Bokhari, MZ | 1 |
| Hussain, Z | 1 |
| Khalid, T | 1 |
| Bokhari, H | 1 |
| Imran, M | 1 |
| Abbasi, SA | 1 |
| Nguyen, HP | 1 |
| Gordon, RA | 1 |
| Hamill, RJ | 1 |
| Tyring, SK | 1 |
| Guy, A | 1 |
| Chinai, N | 1 |
| Ashley, S | 1 |
| Rowe, P | 1 |
| Cunningham, R | 1 |
| Barwell, J | 1 |
| Martins, AR | 1 |
| Branco, P | 1 |
| Gaspar, A | 1 |
| Kumar, S | 1 |
| Minz, M | 1 |
| Sinha, SK | 1 |
| Vaiphei, K | 1 |
| Sharma, A | 1 |
| Singh, S | 1 |
| Kenwar, DB | 1 |
| Pérez Melón, C | 1 |
| Conde Rivera, O | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Rybniker, J | 1 |
| Goede, V | 1 |
| Mertens, J | 1 |
| Ortmann, M | 1 |
| Kulas, W | 1 |
| Kochanek, M | 1 |
| Benzing, T | 1 |
| Arribas, JR | 1 |
| Fätkenheuer, G | 1 |
| Gallieni, M | 1 |
| Chiarelli, G | 1 |
| Olivi, L | 1 |
| Cozzolino, M | 1 |
| Cusi, D | 1 |
| Franz, CC | 1 |
| Bruggisser, M | 1 |
| Krähenbühl, S | 1 |
| Rätz Bravo, AE | 1 |
| Palmisano, A | 1 |
| Benecchi, M | 1 |
| De Filippo, M | 1 |
| Maggiore, U | 1 |
| Buzio, C | 1 |
| Vaglio, A | 1 |
| Kotwal, A | 1 |
| Biswas, D | 1 |
| Sharma, JP | 1 |
| Gupta, A | 1 |
| Jindal, P | 1 |
| Rocha, A | 1 |
| Rodrigues, A | 1 |
| Teixeira, L | 1 |
| Carvalho, MJ | 1 |
| Mendonça, D | 1 |
| Cabrita, A | 1 |
| Bhutada, K | 1 |
| Borkar, SS | 1 |
| Mendiratta, DK | 1 |
| Shende, VR | 1 |
| Godoy, JS | 1 |
| de Souza Bonfim-Mendonça, P | 1 |
| Nakamura, SS | 1 |
| Yamada, SS | 1 |
| Shinobu-Mesquita, C | 1 |
| Pieralisi, N | 1 |
| Fiorini, A | 1 |
| Svidzinski, TI | 1 |
| Tullio, V | 1 |
| Cuffini, AM | 1 |
| Giacchino, F | 1 |
| Mandras, N | 1 |
| Roana, J | 1 |
| Comune, L | 1 |
| Merlino, C | 1 |
| Carlone, NA | 1 |
| Manzano-Gayosso, P | 1 |
| Hernández-Hernández, F | 1 |
| Méndez-Tovar, LJ | 1 |
| González-Monroy, J | 1 |
| López-Martínez, R | 1 |
| Park, SB | 1 |
| Kang, MJ | 1 |
| Whang, EA | 1 |
| Han, SY | 1 |
| Kim, HC | 1 |
| Park, KK | 1 |
| Montenegro, J | 1 |
| Aguirre, R | 1 |
| González, O | 1 |
| Martinez, I | 1 |
| Saracho, R | 1 |
| Berl, T | 1 |
| Wilner, KD | 1 |
| Gardner, M | 1 |
| Hansen, RA | 1 |
| Farmer, B | 1 |
| Baris, BA | 1 |
| Henrich, WL | 1 |
| De Saedeleer, B | 1 |
| Sennesael, J | 1 |
| Van der Niepen, P | 1 |
| Verbeelen, D | 1 |
| Arredondo, G | 1 |
| Martinez-Jorda, R | 1 |
| Calvo, R | 1 |
| Aguirre, C | 1 |
| Suarez, E | 1 |
| Michel, C | 1 |
| Courdavault, L | 1 |
| al Khayat, R | 1 |
| Viron, B | 1 |
| Roux, P | 1 |
| Mignon, F | 1 |
| Goldie, SJ | 1 |
| Kiernan-Tridle, L | 1 |
| Torres, C | 1 |
| Gorban-Brennan, N | 1 |
| Dunne, D | 1 |
| Kliger, AS | 1 |
| Finkelstein, FO | 1 |
| Melez, KA | 1 |
| Cherry, J | 1 |
| Sanchez, C | 1 |
| Ettinger, RB | 1 |
| Walsh, TJ | 1 |
| Wadhwa, NK | 1 |
| Suh, H | 1 |
| Cabralda, T | 1 |
| Dahl, NV | 1 |
| Foote, EF | 1 |
| Searson, KM | 1 |
| Fein, JL | 1 |
| Kapoian, T | 1 |
| Steward, CA | 1 |
| Sherman, RA | 1 |
| Equils, O | 1 |
| Deville, JG | 1 |
| Shapiro, AM | 1 |
| Sanchez, CP | 1 |
| Wanic-Kossowska, M | 1 |
| Kozioł, L | 1 |
| Bajew, L | 1 |
| Roszkowiak, B | 1 |
| Czekalski, S | 1 |
| Anuradha, S | 1 |
| Chatterjee, A | 1 |
| Bajaj, J | 1 |
| Singh, NP | 1 |
| Agarwal, SK | 1 |
| Kaur, R | 1 |
| Kapoor, A | 1 |
| Flechner, SM | 1 |
| O'Malley, K | 1 |
| Paolone, D | 1 |
| File, TM | 1 |
| Cutrona, AF | 1 |
| Morey, A | 1 |
| Lima, C | 1 |
| Matas, B | 1 |
| Munar, MA | 1 |
| Reuman, PD | 1 |
| Neiberger, R | 1 |
| Kondor, DA | 1 |
| Eisinger, RP | 1 |
| Weinstein, MP | 1 |
| Lim, W | 1 |
| Chau, SP | 1 |
| Chan, PC | 1 |
| Cheng, IK | 1 |
| Toon, S | 1 |
| Ross, CE | 1 |
| Gokal, R | 1 |
| Rowland, M | 1 |
| Debruyne, D | 1 |
| Ryckelynck, JP | 1 |
| Moulin, M | 1 |
| Hurault de Ligny, B | 1 |
| Levaltier, B | 1 |
| Bigot, MC | 1 |
| Ahlmén, J | 1 |
| Edebo, L | 1 |
| Eriksson, C | 1 |
| Carlsson, L | 1 |
| Torgersen, AK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efflux Pump Mediated Azole Resistance in Candida Albicans Among Neutropenic Patients With Haematological Malignancies[NCT03659162] | 100 participants (Anticipated) | Observational | 2019-02-17 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fluconazole and Chronic Kidney Failure
| Article | Year |
|---|---|
Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Com | 2010 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
1 trial available for fluconazole and Chronic Kidney Failure
| Article | Year |
|---|---|
Pharmacokinetics of fluconazole in renal failure.
Topics: Creatinine; Female; Fluconazole; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Renal D | 1995 |
34 other studies available for fluconazole and Chronic Kidney Failure
| Article | Year |
|---|---|
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional | 2017 |
A polymorphic, mucocutaneous eruption in a patient with end-stage renal disease.
Topics: Aged, 80 and over; Antifungal Agents; Clostridium Infections; Cryptococcosis; Dermatomycoses; Flucon | 2013 |
Candida arteritis in a pair of renal transplant recipients.
Topics: Aged; Antifungal Agents; Arteritis; Candida albicans; Candidiasis; Fluconazole; Humans; Kidney Failu | 2013 |
Lactobacillus casei Peritonitis in Peritoneal Dialysis: A Rare Case and Literature Review.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Ascitic Fluid; Candida albicans; Fluconazole; Humans | 2016 |
Esophageal tuberculosis with coexisting opportunistic infections in a renal allograft transplant recipient.
Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Candidiasis, Oral; Deglutition Disorders | 2017 |
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Rem | 2009 |
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Topics: Adult; Antifungal Agents; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Device Re | 2011 |
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticholesteremic Agents; Antifungal Agents; Atorvastatin; | 2011 |
Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient.
Topics: Antifungal Agents; Candida; Candidiasis; Discitis; Female; Fluconazole; Humans; Kidney Failure, Chro | 2011 |
An observational study on the epidemiological and mycological profile of Candidemia in ICU patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, F | 2011 |
Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Ceftazidime; Cohort | 2012 |
Successful treatment of peritonitis by C. bertholletiae in a chronic kidney failure patient on continuous ambulatory peritoneal dialysis after kidney rejection.
Topics: Antifungal Agents; Cunninghamella; Drug Administration Routes; Fluconazole; Follow-Up Studies; Graft | 2012 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candid | 2013 |
Combined action of fluconazole and PMNs from uremic patients in clearing intracellular Candida albicans.
Topics: Adult; Aged; Analysis of Variance; Candida albicans; Candidiasis; Case-Control Studies; Chemotaxis, | 2003 |
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acremonium; Aged; Antifungal Agents; Aspergillus; Candida; Child; Drug Resistance, Fungal; Female; F | 2003 |
A case of primary cutaneous aspergillosis in a renal transplant recipient.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Immunocompromised Host; Kidney Failure, Chron | 2004 |
Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter.
Topics: Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Humans; Kidney Failure, | 1995 |
Intraperitoneal fluconazole therapy for Trichosporon cutaneum peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Aged; Ascitic Fluid; Fluconazole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Myco | 1994 |
Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
Topics: Adult; Aged; Fluconazole; Humans; Itraconazole; Kidney Failure, Chronic; Middle Aged; Orosomucoid; P | 1994 |
Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Catheters, Indwelling; Female; | 1996 |
Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Antifungal Agents; Ascitic Fluid; Fluconazole; Hu | 1995 |
Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients.
Topics: Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 1996 |
Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Chromatography, Gas; Dialysis Solutions; Female; F | 1998 |
Penicillium peritonitis in an adolescent receiving chronic peritoneal dialysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Kidney Failure, Chronic; Peni | 1999 |
[Factors causing renal failure in patients with disseminated lupus erythematosus: description of three cases].
Topics: Adult; Antifungal Agents; Antiviral Agents; Candidiasis; Female; Fluconazole; Ganciclovir; Herpes Zo | 1999 |
Trichosporon beigelii peritonitis in a HIV-positive patient on continuous ambulatory peritoneal dialysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Fluconazole; Follow-Up Studies; HIV Seropositivity; Hu | 2000 |
Cryptococcal meningitis in renal transplant patients associated with environmental exposure.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Kidney Failure, Chronic; Kidney Transplantat | 1999 |
[Fluconazole prophylaxis for fungal peritonitis in peritoneal dialysis].
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Diabetic Nephropathies; | 2001 |
Intraperitoneal and intravenous fluconazole pharmokinetics in a pediatric patient with end stage renal disease.
Topics: Candidiasis; Female; Fluconazole; Humans; Infant; Infusions, Intravenous; Kidney Failure, Chronic; P | 1992 |
A bold mold? Paecilomyces variotii peritonitis during continuous ambulatory peritoneal dialysis.
Topics: Adult; Catheters, Indwelling; Female; Fluconazole; Humans; Kidney Failure, Chronic; Mycoses; Paecilo | 1991 |
Histoplasma capsulatum infection associated with continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Histoplasma; Histoplasmosis; Humans; Kidney Failure, Chron | 1991 |
An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.
Topics: Adult; Aged; Chromatography, Gas; Female; Fluconazole; Glomerular Filtration Rate; Half-Life; Humans | 1990 |
Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Aged; Female; Fluconazole; Half-Life; Humans; Injections, Intraperitone | 1990 |
Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report.
Topics: Fluconazole; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Conti | 1989 |